SuperworthCaris Life Sciences market cap CAI
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Oct 23, 2026
- $9B
- Highest close in our data
- $11.1B
- Aug 2025
Caris Life Sciences is worth $9B at the close on Oct 23, 2026, at $32.00 a share.
That is up 3% over the last year.
Its highest close in our data was $11.1B in Aug 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $9B | $4.1B | $9B | +13% |
| 2025 | $8B | $6.7B | $11.1B | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Caris Life Sciences' size, closest first, today.
| Company | Market cap |
|---|---|
| CAICaris Life Sciences | $9B |
| BIOBio-Rad Laboratories | $9.9B |
| LNTHLantheus | $6.5B |
| BLLNBillionToOne | $5.1B |
| RVTYRevvity | $17.7B |
| MEDPMedpace | $18.7B |
| VCYTVeracyte | $3.9B |
| CDNACareDx | $3.6B |
| LHLabcorp | $26.7B |
| DGXQuest Diagnostics | $26.7B |
| MTDMettler-Toledo International | $33.5B |
| Peer median | $13.8B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Caris Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.